Comparing the cost-effectiveness of SGLT2i versus mineralocorticoid antagonists

FHS
June 19, 2023
2:43 pm

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are approved for heart failure with reduced ejection fraction (HFrEF).

aap postpones publication of the consolidated financial statements 2023 due to staff shortages – Biotech Investments

aap Implantate AG / Key word(s): Annual Report aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages 17-Apr-2024

April 18, 2024

Understanding obesity’s effects on liver metabolism

Your liver plays a vital role in your metabolism, the biological process which converts food into energy.

February 26, 2024

‘Last roll of the dice’ for a near-term HIV vaccine fails

A study billed as the last chance to develop an HIV vaccine this decade has been shut down, investigators announced Wednesday at a conference in

December 6, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.